Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Examining Adherence with Different Mediterranean Diet Scoring Systems (P13-032-19).

Reeve E, Feairheller D.

Curr Dev Nutr. 2019 Jun 13;3(Suppl 1). pii: nzz036.P13-032-19. doi: 10.1093/cdn/nzz036.P13-032-19. eCollection 2019 Jun.

2.

Reply to: Deprescribing Attitudes of Older Adults Receiving Medication Management Support from Home-Based Nurses.

Reeve E, Low LF, Hilmer SN.

J Am Geriatr Soc. 2019 Jun 13. doi: 10.1111/jgs.16012. [Epub ahead of print] No abstract available.

PMID:
31190352
3.

Clinicians' Perspectives on Barriers and Enablers of Optimal Prescribing in Patients with Dementia and Coexisting Conditions.

Green AR, Lee P, Reeve E, Wolff JL, Chen CCG, Kruzan R, Boyd CM.

J Am Board Fam Med. 2019 May-Jun;32(3):383-391. doi: 10.3122/jabfm.2019.03.180335.

4.

Pharmacoepidemiology in older people: Purposes and future directions.

Laroche ML, Sirois C, Reeve E, Gnjidic D, Morin L.

Therapie. 2019 Apr;74(2):325-332. doi: 10.1016/j.therap.2018.10.006. Epub 2019 Jan 31.

PMID:
30773343
5.

Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary.

Reeve E, Farrell B, Thompson W, Herrmann N, Sketris I, Magin PJ, Chenoweth L, Gorman M, Quirke L, Bethune G, Hilmer SN.

Med J Aust. 2019 Mar;210(4):174-179. doi: 10.5694/mja2.50015. Epub 2019 Feb 16.

PMID:
30771226
6.

Attitudes of Older Adults and Caregivers in Australia toward Deprescribing.

Reeve E, Low LF, Hilmer SN.

J Am Geriatr Soc. 2019 Jun;67(6):1204-1210. doi: 10.1111/jgs.15804. Epub 2019 Feb 13.

PMID:
30756387
7.

The impact of in hospital patient-education intervention on older people's attitudes and intention to have their benzodiazepines deprescribed: a feasibility study.

Gnjidic D, Ong HMM, Leung C, Jansen J, Reeve E.

Ther Adv Drug Saf. 2019 Jan 17;10:2042098618816562. doi: 10.1177/2042098618816562. eCollection 2019.

8.

Clinical practice guidelines for older people with multimorbidity and life-limiting illness: what are the implications for deprescribing?

Okeowo D, Patterson A, Boyd C, Reeve E, Gnjidic D, Todd A.

Ther Adv Drug Saf. 2018 Sep 12;9(11):619-630. doi: 10.1177/2042098618795770. eCollection 2018 Nov.

9.

Developing a context-specific nutrient profiling system for food policy in Samoa.

Reeve E, Naseri T, Martyn T, Bollars C, Thow AM.

Health Promot Int. 2018 Nov 2. doi: 10.1093/heapro/day089. [Epub ahead of print]

PMID:
30388231
10.

Is the Drug Burden Index Related to Declining Functional Status at Follow-up in Community-Dwelling Seniors Consulting for Minor Injuries? Results from the Canadian Emergency Team Initiative Cohort Study.

Kröger E, Simard M, Sirois MJ, Giroux M, Sirois C, Kouladjian-O'Donnell L, Reeve E, Hilmer S, Carmichael PH, Émond M.

Drugs Aging. 2019 Jan;36(1):73-83. doi: 10.1007/s40266-018-0604-9.

PMID:
30378088
11.

Assessment of Attitudes Toward Deprescribing in Older Medicare Beneficiaries in the United States.

Reeve E, Wolff JL, Skehan M, Bayliss EA, Hilmer SN, Boyd CM.

JAMA Intern Med. 2018 Dec 1;178(12):1673-1680. doi: 10.1001/jamainternmed.2018.4720.

PMID:
30326004
12.

How general practitioners would deprescribe in frail oldest-old with polypharmacy - the LESS study.

Mantelli S, Jungo KT, Rozsnyai Z, Reeve E, Luymes CH, Poortvliet RKE, Chiolero A, Rodondi N, Gussekloo J, Streit S.

BMC Fam Pract. 2018 Oct 12;19(1):169. doi: 10.1186/s12875-018-0856-9.

13.

Deprescribing: Future directions for research.

Thompson W, Reeve E, Moriarty F, Maclure M, Turner J, Steinman MA, Conklin J, Dolovich L, McCarthy L, Farrell B.

Res Social Adm Pharm. 2019 Jun;15(6):801-805. doi: 10.1016/j.sapharm.2018.08.013. Epub 2018 Sep 18.

PMID:
30241876
14.

Deprescribing guidelines: An international symposium on development, implementation, research and health professional education.

Farrell B, Conklin J, Dolovich L, Irving H, Maclure M, McCarthy L, Moriarty F, Pottie K, Raman-Wilms L, Reeve E, Thompson W.

Res Social Adm Pharm. 2019 Jun;15(6):780-789. doi: 10.1016/j.sapharm.2018.08.010. Epub 2018 Sep 18.

PMID:
30241875
15.

Development and pilot testing of the revised Patients' Attitudes Towards Deprescribing questionnaire for people with cognitive impairment.

Reeve E, Anthony AC, Kouladjian O'Donnell L, Low LF, Ogle SJ, Glendenning JE, Lorang CE, Hilmer SN.

Australas J Ageing. 2018 Dec;37(4):E150-E154. doi: 10.1111/ajag.12576. Epub 2018 Aug 6.

PMID:
30084180
16.

Implementation lessons for school food policies and marketing restrictions in the Philippines: a qualitative policy analysis.

Reeve E, Thow AM, Bell C, Engelhardt K, Gamolo-Naliponguit EC, Go JJ, Sacks G.

Global Health. 2018 Jan 23;14(1):8. doi: 10.1186/s12992-017-0320-y.

17.

Food supply, nutrition and trade policy: reversal of an import ban on turkey tails.

Thow AM, Reeve E, Naseri T, Martyn T, Bollars C.

Bull World Health Organ. 2017 Oct 1;95(10):723-725. doi: 10.2471/BLT.17.192468. Epub 2017 Aug 23. No abstract available.

18.

A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.

Reeve E, Moriarty F, Nahas R, Turner JP, Kouladjian O'Donnell L, Hilmer SN.

Expert Opin Drug Saf. 2018 Jan;17(1):39-49. doi: 10.1080/14740338.2018.1397625. Epub 2017 Nov 6. Review.

PMID:
29072544
19.

Documenting the prevalence of hiatal hernia and oesophageal abnormalities in brachycephalic dogs using fluoroscopy.

Reeve EJ, Sutton D, Friend EJ, Warren-Smith CMR.

J Small Anim Pract. 2017 Dec;58(12):703-708. doi: 10.1111/jsap.12734. Epub 2017 Sep 30.

PMID:
28963795
20.

Clinician agreement and influence of medication-related characteristics on assessment of polypharmacy.

Ong GJ, Page A, Caughey G, Johns S, Reeve E, Shakib S.

Pharmacol Res Perspect. 2017 May 31;5(3):e00321. doi: 10.1002/prp2.321. eCollection 2017 Jun.

21.

Pharmacokinetic and pharmacodynamic alterations in older people with dementia.

Reeve E, Trenaman SC, Rockwood K, Hilmer SN.

Expert Opin Drug Metab Toxicol. 2017 Jun;13(6):651-668. doi: 10.1080/17425255.2017.1325873. Epub 2017 May 10. Review.

PMID:
28460576
22.

A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people.

Reeve E, Ong M, Wu A, Jansen J, Petrovic M, Gnjidic D.

Eur J Clin Pharmacol. 2017 Aug;73(8):927-935. doi: 10.1007/s00228-017-2257-8. Epub 2017 Apr 30. Review.

PMID:
28456823
23.

Tapering or abrupt cessation of proton pump inhibitors?

Reeve E, Hilmer S.

Eur J Clin Pharmacol. 2017 Jul;73(7):923-924. doi: 10.1007/s00228-017-2238-y. Epub 2017 Mar 22. No abstract available.

PMID:
28326435
24.

Exploration of verbal repetition in people with dementia using an online symptom-tracking tool.

Reeve E, Molin P, Hui A, Rockwood K.

Int Psychogeriatr. 2017 Jun;29(6):959-966. doi: 10.1017/S1041610216002180. Epub 2017 Mar 9.

25.

Multisensory cue combination after sensory loss: Audio-visual localization in patients with progressive retinal disease.

Garcia SE, Jones PR, Reeve EI, Michaelides M, Rubin GS, Nardini M.

J Exp Psychol Hum Percept Perform. 2017 Apr;43(4):729-740. doi: 10.1037/xhp0000344. Epub 2017 Feb 9.

PMID:
28182481
26.

Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action.

Reeve E, Thompson W, Farrell B.

Eur J Intern Med. 2017 Mar;38:3-11. doi: 10.1016/j.ejim.2016.12.021. Epub 2017 Jan 5. Review.

PMID:
28063660
27.

Medicine information exchange networks among healthcare professionals and prescribing in geriatric medicine wards.

Chan B, Reeve E, Matthews S, Carroll PR, Long JC, Held F, Latt M, Naganathan V, Caplan GA, Hilmer SN.

Br J Clin Pharmacol. 2017 Jun;83(6):1185-1196. doi: 10.1111/bcp.13222. Epub 2017 Feb 1.

28.
29.

Community-dwelling older people's attitudes towards deprescribing in Canada.

Sirois C, Ouellet N, Reeve E.

Res Social Adm Pharm. 2017 Jul - Aug;13(4):864-870. doi: 10.1016/j.sapharm.2016.08.006. Epub 2016 Aug 31.

PMID:
27663392
30.

The Ethics of Deprescribing in Older Adults.

Reeve E, Denig P, Hilmer SN, Ter Meulen R.

J Bioeth Inq. 2016 Dec;13(4):581-590. doi: 10.1007/s11673-016-9736-y. Epub 2016 Jul 14.

PMID:
27416980
31.

Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study.

Reeve E, Low LF, Hilmer SN.

Br J Gen Pract. 2016 Aug;66(649):e552-60. doi: 10.3399/bjgp16X685669. Epub 2016 Jun 6.

32.

Health Care Practitioners' Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older Adults.

Kouladjian L, Gnjidic D, Reeve E, Chen TF, Hilmer SN.

Ann Pharmacother. 2016 Aug;50(8):625-36. doi: 10.1177/1060028016652997. Epub 2016 Jun 1.

PMID:
27257284
33.
34.

Enhancing Education Activities for Health Care Trainees and Professionals Using Audience Response Systems: A Systematic Review.

Grzeskowiak LE, Thomas AE, To J, Phillips AJ, Reeve E.

J Contin Educ Health Prof. 2015 Fall;35(4):261-9. doi: 10.1097/01.CEH.0000473130.55806.87. Review.

PMID:
26953857
35.

Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy.

Galazzi A, Lusignani M, Chiarelli MT, Mannucci PM, Franchi C, Tettamanti M, Reeve E, Nobili A.

Int J Clin Pharm. 2016 Apr;38(2):454-61. doi: 10.1007/s11096-016-0279-4. Epub 2016 Mar 7.

PMID:
26951120
36.

Are residents of aged care facilities willing to have their medications deprescribed?

Kalogianis MJ, Wimmer BC, Turner JP, Tan EC, Emery T, Robson L, Reeve E, Hilmer SN, Bell JS.

Res Social Adm Pharm. 2016 Sep-Oct;12(5):784-8. doi: 10.1016/j.sapharm.2015.12.004. Epub 2015 Dec 19.

PMID:
26850702
37.

Prevalence of statin-drug interactions in older people: a systematic review.

Thai M, Reeve E, Hilmer SN, Qi K, Pearson SA, Gnjidic D.

Eur J Clin Pharmacol. 2016 May;72(5):513-21. doi: 10.1007/s00228-016-2011-7. Epub 2016 Jan 20. Review.

PMID:
26790666
38.

Prevalence of Potential and Clinically Relevant Statin-Drug Interactions in Frail and Robust Older Inpatients.

Thai M, Hilmer S, Pearson SA, Reeve E, Gnjidic D.

Drugs Aging. 2015 Oct;32(10):849-56. doi: 10.1007/s40266-015-0302-9.

PMID:
26442861
39.

Barriers to Optimising Prescribing and Deprescribing in Older Adults with Dementia: A Narrative Review.

Reeve E, Bell JS, Hilmer SN.

Curr Clin Pharmacol. 2015;10(3):168-77. Review.

PMID:
26338170
40.

Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.

Qi K, Reeve E, Hilmer SN, Pearson SA, Matthews S, Gnjidic D.

Int J Clin Pharm. 2015 Oct;37(5):949-57. doi: 10.1007/s11096-015-0147-7. Epub 2015 Jun 6.

PMID:
26047944
41.

Enhancing continuing education activities using audience response systems: a single-blind controlled trial.

Grzeskowiak LE, Thomas AE, To J, Reeve E, Phillips AJ.

J Contin Educ Health Prof. 2015 Winter;35(1):38-45. doi: 10.1002/chp.21269.

PMID:
25799971
42.

Reducing inappropriate polypharmacy: the process of deprescribing.

Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, Gnjidic D, Del Mar CB, Roughead EE, Page A, Jansen J, Martin JH.

JAMA Intern Med. 2015 May;175(5):827-34. doi: 10.1001/jamainternmed.2015.0324.

PMID:
25798731
43.

Alterations in drug disposition in older adults.

Reeve E, Wiese MD, Mangoni AA.

Expert Opin Drug Metab Toxicol. 2015 Apr;11(4):491-508. doi: 10.1517/17425255.2015.1004310. Epub 2015 Jan 19. Review.

PMID:
25600059
44.

Patients' perspectives on the brave new word 'deprescribing'.

Reeve E, Turner JP.

Int J Pharm Pract. 2015 Feb;23(1):90-1. doi: 10.1111/ijpp.12111. No abstract available.

PMID:
25594318
45.

Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors.

Reeve E, Andrews JM, Wiese MD, Hendrix I, Roberts MS, Shakib S.

Ann Pharmacother. 2015 Jan;49(1):29-38. doi: 10.1177/1060028014558290. Epub 2014 Nov 10.

PMID:
25385826
46.

The benefits and harms of deprescribing.

Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD.

Med J Aust. 2014 Oct 6;201(7):386-9.

PMID:
25296058
47.

The role of the OncPal deprescribing guideline in end-of-life care.

Reeve E, Gnjidic D, Hilmer S.

Support Care Cancer. 2015 Apr;23(4):899. doi: 10.1007/s00520-014-2445-3. Epub 2014 Sep 24. No abstract available.

PMID:
25245777
48.

Analgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: a cross-sectional, multisite, epidemiological study protocol.

Tan EC, Visvanathan R, Hilmer SN, Vitry AI, Quirke T, Emery T, Robson L, Shortt T, Sheldrick S, Lee SS, Clothier R, Reeve E, Gnjidic D, Ilomäki J, Bell JS.

BMJ Open. 2014 Jun 19;4(6):e005757. doi: 10.1136/bmjopen-2014-005757.

49.

Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process.

Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD.

Br J Clin Pharmacol. 2014 Oct;78(4):738-47. doi: 10.1111/bcp.12386.

50.

Benefits of deprescribing on patients' adherence to medications.

Reeve E, Wiese MD.

Int J Clin Pharm. 2014 Feb;36(1):26-9. doi: 10.1007/s11096-013-9871-z.

PMID:
24242974

Supplemental Content

Support Center